La narrativa como herramientas para el abordaje psicosocial en escenarios de violencia.

El conflicto armado en Colombia podríamos decir que se dio a mediados de 1946 cuando los partidos conservadores y liberales por la disputa del poder se alzaron en armas, llevando consigo un sin números de eventos que más tarde traería como consecuencias problemas económicos, políticos y social, desde entonces estos grupos políticos que más adelantes seria reconocidos como ejército, guerrillas, paramilitares y bandas delincuenciales comenzarían una lucha incansable por tomar el poder y control territorial. Como consecuencia de los mencionados se han afectados un sinnúmeros de población, donde todos los estatus socioeconómicos se han visto sumergido en tal crisis, el desplazamiento forzado, el reclutamiento de menores, la muertes de personas inocentes y campesinas, el narcotráfico, entre otros, son algunas de tantas consecuencias que ha dejado como herencia la falta de un acuerdo político en Colombia. En el siguiente trabajo se encontraran dos ejemplos de muchos, que podemos encontrar como consecuencia del flagelo de la violencia de nuestro país, y que hoy como profesionales en el área de la salud mental buscamos aportar nuestro grano de arena en la reconciliación y reconstrucción de una vida digna. Los invitamos a que de manera reflexiva y crítica evalúen las estrategias y metodologías que propone el diplomado de intervención psicosocial en escenarios de violencia, donde de manera conjunta trataremos de buscar herramientas de participación para las personas más vulnerables, como lo son las víctimas del conflicto armado.The armed conflict in Colombia could be said to have occurred in mid-1946 when the conservative and liberal political groups for the dispute over power took up arms, bringing with them a number of events that later would bring economic, political and social problems as a result. Since then these political groups that would later be recognized as army, guerrillas, paramilitaries and criminal bands would begin a tireless struggle to seize power and territorial control. As a consequence of the aforementioned, a large number of people have been affected, where all socioeconomic status has been submerged in such a crisis, forced displacement, the recruitment of minors, the deaths of innocent and peasant people, drug trafficking, among others; These are some of the many magnitudes that the lack of a political agreement in Colombia has left as an inheritance. In the following work you will find two examples of many, which can be found as a result of the scourge of violence in our country, and today as professionals in the area of mental health we seek to contribute our grain of sand in the reconciliation and reconstruction of a dignified life. We invite you to reflectively and critically evaluate the strategies and methodologies proposed by the psychosocial intervention qualification in scenarios of violence; where we will jointly try to find participation tools for the most vulnerable people, such as the victims of the armed conflict

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Acueducto del Padre Tembleque. Patrimonio de la Humanidad

Este libro reúne las investigaciones de un grupo de académicos de la Universidad Autónoma del Estado de México, cuyo principal objetivo es poner en perspectiva la construcción de Tembleque desde diversas áreas del conocimiento. Las indagaciones del complejo hidráulico van desde el estudio arquitectónico, ecológico, ambiental, de biodiversidad, de ingeniería estructural e histórico, este último es fundamental para entender el contexto y la cultura en la cual se desarrolló, porque toda obra arquitectónica está íntimamente relacionada con su entorno. Los investigadores realizan una tarea extensa de las condiciones materiales del acueducto y las condiciones geográficas de la zona donde se encuentra y hacen énfasis en los acontecimientos históricos que sirven como punto de partida para su estudio. Este texto es producto de un esfuerzo colaborativo y multidisciplinario, encaminado a la exploración de las circunstancias que rodearon la edificación del Acueducto del Padre Tembleque

Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

BACKGROUND: Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients with type 2 diabetes mellitus (T2DM). Furthermore, patients with T2DM and acute coronary syndrome (ACS) have a particularly high risk of CV events. The glucagon-like peptide 1 receptor agonist, lixisenatide, improves glycemia, but its effects on CV events have not been thoroughly evaluated. METHODS: ELIXA (www.clinicaltrials.gov no. NCT01147250) is a randomized, double-blind, placebo-controlled, parallel-group, multicenter study of lixisenatide in patients with T2DM and a recent ACS event. The primary aim is to evaluate the effects of lixisenatide on CV morbidity and mortality in a population at high CV risk. The primary efficacy end point is a composite of time to CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for unstable angina. Data are systematically collected for safety outcomes, including hypoglycemia, pancreatitis, and malignancy. RESULTS: Enrollment began in July 2010 and ended in August 2013; 6,068 patients from 49 countries were randomized. Of these, 69% are men and 75% are white; at baseline, the mean ± SD age was 60.3 ± 9.7 years, body mass index was 30.2 ± 5.7 kg/m(2), and duration of T2DM was 9.3 ± 8.2 years. The qualifying ACS was a myocardial infarction in 83% and unstable angina in 17%. The study will continue until the positive adjudication of the protocol-specified number of primary CV events. CONCLUSION: ELIXA will be the first trial to report the safety and efficacy of a glucagon-like peptide 1 receptor agonist in people with T2DM and high CV event risk